Canada • Toronto Stock Exchange • TSX:WEED • CA1380357048
The current stock price of WEED.CA is 1.49 CAD. In the past month the price decreased by -13.87%. In the past year, price decreased by -44.4%.
ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA. The financial health of WEED.CA is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months WEED.CA reported a non-GAAP Earnings per Share(EPS) of -1.84. The EPS increased by 64.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -36.07% | ||
| ROE | -52.42% | ||
| Debt/Equity | 0.33 |
13 analysts have analysed WEED.CA and the average price target is 3.44 CAD. This implies a price increase of 131.04% is expected in the next year compared to the current price of 1.49.
For the next year, analysts expect an EPS growth of 94.65% and a revenue growth 2.14% for WEED.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.44 | 3.1B | ||
| GSD | DEVONIAN HEALTH GROUP INC | N/A | 1.659B | ||
| CRON | CRONOS GROUP INC | 37.46 | 1.39B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.234B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.02 | 887.271M | ||
| GUD | KNIGHT THERAPEUTICS INC | 122.36 | 582.832M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 397.224M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 27.01 | 366.343M | ||
| TSND | TERRASCEND CORP | N/A | 316.695M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The firm delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
CANOPY GROWTH CORP
1 Hershey Dr
Smiths Falls ONTARIO K7A 0A8 CA
CEO: David Klein
Employees: 960
Phone: 18555589333
Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The company is headquartered in Smiths Falls, Ontario and currently employs 960 full-time employees. The company went IPO on 2010-06-04. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The firm delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
The current stock price of WEED.CA is 1.49 CAD. The price decreased by -0.67% in the last trading session.
WEED.CA does not pay a dividend.
WEED.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
CANOPY GROWTH CORP (WEED.CA) currently has 960 employees.